DOCSLIB.ORG

Collagen-Based Matrix Matrix Auf Der Basis Von Kollagen Matrice À Base De Collagène

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Collagen-Based Matrix Matrix Auf Der Basis Von Kollagen Matrice À Base De Collagène Europäisches Patentamt *EP000693523B1* (19) European Patent Office Office européen des brevets (11) EP 0 693 523 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C08H 1/06, A61L 27/00, of the grant of the patent: A61L 31/00 20.11.2002 Bulletin 2002/47 (21) Application number: 95111260.6 (22) Date of filing: 18.07.1995 (54) Collagen-based matrix Matrix auf der Basis von Kollagen Matrice à base de collagène (84) Designated Contracting States: • Noff, Matityahu AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL Rehovot 76228 (IL) PT SE (74) Representative: Grünecker, Kinkeldey, (30) Priority: 19.07.1994 IL 11036794 Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 (43) Date of publication of application: 80538 München (DE) 24.01.1996 Bulletin 1996/04 (56) References cited: (73) Proprietor: COL-BAR R & D LTD. DE-A- 4 302 708 FR-A- 2 679 778 Ramat-Gan 52290 (IL) US-A- 4 971 954 (72) Inventors: Remarks: • Pitaru, Sandu The file contains technical information submitted Tel-Aviv 62300 (IL) after the application was filed and not included in this specification Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 0 693 523 B1 Printed by Jouve, 75001 PARIS (FR) EP 0 693 523 B1 Description [0001] The present invention concerns a collagen-based matrix and devices comprising this matrix. A particular example of such device is a collagen-based sheet useful in a guided tissue regeneration (GTR), which will be referred 5 to herein as "GTR membrane". [0002] A particular application of the GTR membrane of the invention is in dentistry, for guided tissue regeneration of periodontal tissue. [0003] The present invention also concerns a process for the preparation of the matrix. [0004] Guided tissue regeneration is a surgical procedure intended to restore or regenerate the morphology and 10 function of tissues or organs that were destroyed by disease or trauma. In tissue regeneration, the regenerating tissues have to repopulate the same site and space previously occupied by the healthy tissues that were destroyed. Further- more, to restore the morphological and functional relationships between the different regeneration tissues at the re- generation site, the repopulation of the affected site and the subsequent differentiation of the repopulating cells should be an orderly and concerted process. 15 [0005] The technique of GTR aims to allow orderly and concerted repopulation of an affected site by regenerating tissues. To this end, a barrier is interposed between the regenerating tissues and the tissue that might intervene with the regenerative process. The barrier is maintained in place until the affected site is repopulated by the proper tissues and the regenerating tissues reach maturity. [0006] Membrane barriers are currently used mainly in dentistry, for GTR of regenerating periodontal tissues that 20 were destroyed by periodontal disease or trauma. Generally, two types of membranes are in use, membranes made of non-degradable material and membranes made of degradable materials. [0007] Collagen are a family of proteins with a well determined triple helical configuration. Among these proteins, collagen Type I is most prevalent, constituting approximately 25% of the body's proteins and 80% of the connective tissues' proteins. Collagen Type I polymerizes to form aggregates of fibers and bundles. Collagen is continuously 25 remodeled in the body by degradation and synthesis. Collagen Type I is degraded only by a specific enzyme - colla- genase, and is resistant to any non-specific proteolytic degradation. [0008] Collagen is a weak antigen and most of its antigenicity resides in the non-helical terminals of the molecule. These terminals may be removed by enzymes such as pepsin. Its weak antigenicity and its relative resistance to degradation make collagen a good candidate as a building material of implantable devices. 30 [0009] A molecular solution of type I collagen can be prepared from a connective tissue rich in this protein and the molecular collagen can then be reassembled into fibrils which can then combine to form a collagen matrix. Collagen matrices can be molded in vitro into numerous implantable devices such as, for example collagen sheets or collagen tubes. [0010] When used to form implantable devices, collagen matrices should maintain their integrity for long periods of 35 time. The resistance towards degradation of the collagen fibrils can be increased by increasing the number of inter- molecular cross-links. Several agents, such as aldehyde fixatives and imides, and treatments such as radiations have been used to achieve this purpose. The main drawbacks of such treatments are toxicity and inability to accurately control the degree of cross-linking. [0011] US-A-4,971,954 is related to the provision of glycated collagen based matrices useful as an implant in clinical 40 and veterinary applications which support the growth of connective tissue cells and particularly allow fibroblast in- growth. [0012] It is the object of the present invention to provide a collagen matrix suitable for use in implantable devices such as membranes or tubes for guided tissue regeneration. [0013] It is furthermore the object of the present invention to provide a process for the preparation of such a matrix. 45 [0014] It is still further the object of the present invention to provide a kit comprising ingredients useful in guided tissue regeneration procedures, e.g. comprising space maintainers for use in guided tissue regeneration (GTR) pro- cedures. [0015] According to the first aspect of the present invention, said object is attained by a process for the preparation of a collagen matrix from collagen comprising: 50 (i) dissolving said collagen in a solvent; (ii) transferring said dissolved collagen to a mold and incubating it to obtain a membrane; (iii) compressing said membrane until a desired membrane thickness is obtained; (iv) reacting said compressed membrane with a reducing sugar or a reducing sugar derivative which is capable of 55 existing in an aldehyde or ketone state in an aqueous solution, to crosslink fibrils of the collagen to one another, thus forming a matrix; and (v) subjecting said matrix to critical point drying. 2 EP 0 693 523 B1 [0016] The process may further comprise after step (iv) the step of dehydrating said matrix prior to critical point drying. [0017] The present invention further provides a collagen matrix obtainable by the above process and an implantable device comprising said collagen matrix. [0018] The present invention is also directed to the use of said implantable device as a membrane barrier for guided 5 tissue regeneration. [0019] Furthermore, the present invention provides a kit for use in guided tissue regeneration, comprising said im- plantable device as a tissue regeneration guidance membrane and a substance for use as a space maintainer, said space maintainer being hyaluronic acid. [0020] The collagen matrix of the present invention comprises collagen fibrils, the molecules or microfibrils of which 10 are being cross-linked to one another by a cross-linking agent, the cross-linking agent comprising a reducing sugar, or a reducing sugar derivative. [0021] The process of the present invention for preparing a collagen matrix comprises reacting collagen with a re- ducing agent whereby fibrils of the collagen become cross-linked to one another. Preferably, following preparation, the collagen matrix is dehydrated, e.g. in alcohol solution, and then subjected to critical point drying. 15 [0022] Said cross-linking agent may be an aldehyde mono sugar or a mono sugar derivative wherein the α-carbon exists in an aldehyde or ketone state in an aqueous solution. [0023] Said cross-linking agent may be a compound represented by one of the following formulae I or II: 20 25 30 wherein: 35 R1 is H or lower alkyl or alkylene, an amino acid, a peptide, a saccharide, purine or pyrimidine base, a phospho- rylated purine or pyrimidine base; n is an integer between 2-9, and p and q are each independently an integer between 0 to 8, provided that p and q together are at least 2 and not 40 more than 8. [0024] A reducing sugar can form a Schiff base with an α or ε amino groups of amino acids of the collagen molecule. The Schiff base undergoes an Amadori Rearrangement to form a ketoamine product by the following reaction scheme: 45 50 55 3 EP 0 693 523 B1 a. Aldehyde sugar [0025] 5 10 15 20 25 30 b. Ketone sugar [0026] 35 40 45 50 55 4 EP 0 693 523 B1 5 10 [0027] Two adjacent ketoamine groups can then condense to form a stable intermolecular or intramolecular crosslink. 15 [0028] When the cross-linking agent is ribose, a stable product cross-linked via a pentosidine group may be formed by the following reaction scheme (in the following scheme "A" denotes a first collagen molecule and "B" a second collagen molecule): 20 25 30 35 40 45 50 55 5 EP 0 693 523 B1 5 10 15 20 [0029] Examples of said reducing agent are glycerose, threose, erythrose, lyxose, xylose, arabinose, ribose, allose, altrose, glucose, mannose, gulose, idose, galactose, talose, or any other diose, triose, tetrose, pentose, hexose, sep- tose, octose, nanose or decose. [0030] The degradation rate of the collagen matrix when in situ can be controlled by the extent of cross-linking between the collagen molecules in the matrix. This may in turn be controlled by the concentration of the sugar during 25 the preparation of the matrix, the temperature, and the extent of time during which the collagen is exposed to the sugar.
Load more

Recommended publications
  • Uvic Thesis Template
    Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in the Department of Biochemistry and Microbiology Kaleigh Giles, 2014 University of Victoria All rights reserved. This thesis may not be reproduced in whole or in part, by photocopy or other means, without the permission of the author. ii Supervisory Committee Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger (Department of Biochemistry and Microbiology) Departmental Member Dr. Fraser Hof (Department of Chemistry) Outside Member iii Abstract Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger, Department of Biochemistry and Microbiology Departmental Member Dr. Fraser Hof, Department of Chemistry O utside Member Agarose and porphyran are related galactans that are only found within red marine algae. As such, marine microorganisms have adapted to using these polysaccharides as carbon sources through the acquisition of unique Carbohydrate Active enZymes (CAZymes). A recent metagenome study of the microbiomes from a Japanese human population identified putative CAZymes in several bacterial species, including Bacteroides plebeius that have significant amino acid sequence similarity with those from marine bacteria. Analysis of one potential CAZyme from B. plebeius (BpGH50) is described here. While displaying up to 30% sequence identity with β-agarases, BpGH50 has no detectable agarase activity. Its crystal structure reveals that the topology of the active site is much different than previously characterized agarases, while containing the same core catalytic machinery.
    [Show full text]
  • United States Patent Office
    - 2,926,180 United States Patent Office Patented Feb. 23, 1960 2 cycloalkyl, etc. These substituents R and R' may also be substituted with various groupings such as carboxyl 2,926,180 groups, sulfo groups, halogen atoms, etc. Examples of CONDENSATION OF AROMATIC KETONES WITH compounds which are included within the scope of this CARBOHYDRATES AND RELATED MATER ALS 5 general formula are acetophenone, propiophenone, benzo Carl B. Linn, Riverside, Ill., assignor, by mesne assign phenone, acetomesitylene, phenylglyoxal, benzylaceto ments, to Universal Oil Products Company, Des phenone, dypnone, dibenzoylmethane, benzopinacolone, Plaines, Ill., a corporation of Delaware dimethylaminobenzophenone, acetonaphthalene, benzoyl No Drawing. Application June 18, 1957 naphthalene, acetonaphthacene, benzoylnaphthacene, ben 10 zil, benzilacetophenone, ortho-hydroxyacetophenone, para Serial No. 666,489 hydroxyacetophenone, ortho - hydroxy-para - methoxy 5 Claims. (C. 260-345.9) acetophenone, para-hydroxy-meta-methoxyacetophenone, zingerone, etc. This application is a continuation-in-part of my co Carbohydrates which are condensed with aromatic pending application Serial No. 401,068, filed December 5 ketones to form a compound selected from the group 29, 1953, now Patent No. 2,798,079. consisting of an acylaryl-desoxy-alditol and an acylaryl This invention relates to a process for interacting aro desoxy-ketitol include simple sugars, their desoxy- and matic ketones with carbohydrates and materials closely omega-carboxy derivatives, compound sugars or oligo related to carbohydrates. The process relates more par saccharides, and polysaccharides. ticularly to the condensation of simple sugars, their 20 Simple sugars include dioses, trioses, tetroses, pentoses, desoxy- and their omega-carboxy derivatives, compound hexoses, heptoses, octoses, nonoses, and decoses. Com sugars or oligosaccharides, and polysaccharides with aro pound sugars include disaccharides, trisaccharides, and matic ketones in the presence of a hydrogen fluoride tetrasaccharides.
    [Show full text]
  • Proquest Dissertations
    Feeding and oviposition behavior of tobacco hornworms, Manduca sexta, in relation to Myo-inositol Item Type text; Thesis-Reproduction (electronic) Authors Nelson, Nancy Marie, 1968- Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 07/10/2021 15:39:03 Link to Item http://hdl.handle.net/10150/278543 INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book.
    [Show full text]
  • Glycoconjugates
    Background Information on Glycoconjugates Richard D. Cummings, Ph.D. Director, National Center for Functional Glycomics Professor Department of Surgery Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA 02114 Tel: (617) 735-4643 e-mail: [email protected] For General Reference On-Line See: Essentials of Glycobiology (2nd Edition) Varki, Cummings, Esko, Freeze, Stanley, Bertozzi, Hart and Etzler) http://www.ncbi.nlm.nih.gov/books/NBK1908/ Mammalian Cells are Covered with Glycoconjugates GLYCOSAMINOGLYCANS/ GLYCOPROTEINS PROTEOGLYCANS GLYCOLIPIDS NUCLEAR/CYTOPLASMIC GLYCOPROTEINS 2 Mammalian Glycoconjugates are Recognized by a Wide Variety of Specific Proteins GLYCAN-BINDING PROTEIN (GBP) GBP ANTIBODY TOXIN GBP GBP VIRUS 7 ANTIBODY GBP MICROBE TOXIN 3 Glycosylation Pathways 4 Glycosylation Pathways 5 Glycoconjugates, Which are Molecules Containing Sugars (Monosaccharides) Linked Within Them, are the Major Constituents of Animal Cell Membranes (Glycocalyx) and Secreted Material: See Different Classes of Glycoconjugates Below in Red Boxes PROTEOGLYCANS GLYCOSAMINOGLYCANS GLYCOSAMINOGLYCANS GLYCOPROTEINS GPI-ANCHORED GLYCOPROTEINS GLYCOLIPIDS outside Cell Membrane cytoplasm Essentials of Glycobiology, 3rd Edition CYTOPLASMIC GLYCOPROTEINS Chapter 1, Figure 6 Glycans are as Ubiquitous as DNA/RNA and Appear to Represent Greater Molecular Diversity 7 Big Picture: Nucleotide Sugars Connection of • UDP-Glc, • UDP-Gal, • UDP-GlcNAc, Glycoconjugate • UDPGalNAc, • UDP-GlcA, Biosynthesis • UDP-Xyl, • GDP-Man, • GDP-Fuc, to Intermediary • CMP-Neu5Ac used for synthesizing Metabolism glycoconjugates, e.g, glycoproteins & glycolipids 8 Important Topics to Consider 1. The different types of monosaccharides found in animal cell glycoconjugates 2. The different types of glycoconjugates and their differences, e.g. glycoproteins, glycolipids 3. The nucleotide sugars, glycosyltransferases, glycosidases, transporters, endoplasmic reticulum, and Golgi in terms of their roles in glycoconjugate biosynthesis and turnover 4.
    [Show full text]
  • Pyrolysis of the Simplest Carbohydrate, Glycolaldehyde (CHO-CH2OH), and Glyoxal in a Heated Micro-Reactor
    Pyrolysis of the Simplest Carbohydrate, Glycolaldehyde (CHO-CH2OH), and Glyoxal in a Heated Micro-Reactor Jessica Porterfield1, Joshua H. Baraban1, Tyler P. Troy2, Musahid Ahmed2, Michael C. McCarthy3, Kathleen M. Morgan4, John W. Daily5, Thanh Lam Nguyen6, John F. Stanton6, G. Barney Ellison1 1Department of Chemistry and Biochemistry, University of Colorado, Boulder, 80309- 0215, U.S.A., 2Chemical Sciences Division, Lawrence Berkeley National Laboratories, Berkeley, CA 94720, U.S.A., 3Harvard-Smithsonian Center for Astrophysics, Cambridge, MA 02138, 4Department of Chemistry , Xavier University of Louisiana , New Orleans, LA 70125-1098, 5Center for Combustion and Environmental Research, Department of Mechanical Engineering, University of Colorado, Boulder, CO 80309-0427, U.S.A., and 6Department of Chemistry; University of Texas at Austin; Austin, TX 78712. E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] E-mail: [email protected] Email: [email protected] J. Physical Chemistry A (revised, March 2016) - 2 - Abstract Both glycolaldehyde and glyoxal have been pyrolyzed in a set of flash- pyrolysis micro-reactors. The pyrolysis products resulting from CHO-CH2OH and HCO-CHO were detected and identified by VUV photoionization mass spectrometry. Complementary product identification was provided by argon matrix infrared absorption spectroscopy. Pyrolysis pressures in the micro- reactor were roughly 100 Torr and contact times with the micro-reactors were approximately 100 µsec. At 1200 K, the products of glycolaldehyde pyrolysis are: H atoms, CO, CH2=O, CH2=C=O, HCO-CHO.
    [Show full text]
  • Intermediate Transfer Type Ink Jet Recording Method
    Europaisches Patentamt J European Patent Office © Publication number: 0 606 490 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC © Application number: 93914949.8 int. ci.5: B41J 2/01 @ Date of filing: 02.07.93 © International application number: PCT/JP93/00914 © International publication number: WO 94/01283 (20.01.94 94/03) © Priority: 02.07.92 JP 175384/92 Inventor: HOSONO, Yoshie 02.07.92 JP 175385/92 Seiko Epson Corporation, 02.07.92 JP 175386/92 3-5, Owa 3-chome 02.07.92 JP 175387/92 Suwa-shi, Nagano 392(JP) 16.10.92 JP 278938/92 Inventor: NAKAMURA, Hiroto 05.11.92 JP 296109/92 Seiko Epson Corporation, 05.11.92 JP 296110/92 3-5, Owa 3-chome 05.11.92 JP 296111/92 Suwa-shi, Nagano 392(JP) 06.01.93 JP 665/93 Inventor: KOIKE, Yoshiyuki Seiko Epson Corporation, © Date of publication of application: 3-5, Owa 3-chome 20.07.94 Bulletin 94/29 Suwa-shi, Nagano 392(JP) Inventor: MATSUZAKI, Makoto @ Designated Contracting States: Seiko Epson Corporation, CH DE FR GB IT LI NL SE 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Applicant: SEIKO EPSON CORPORATION Inventor: UEHARA, Fumie 4-1, Nishishinjuku 2-chome Seiko Shinjuku-ku Tokyo 163(JP) Epson Corporation, 3-5, Owa 3-chome © Inventor: FUJINO, Makoto Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, Inventor: ISHIBASHI, Osamu 3-5, Owa 3-chome Seiko Epson Corporation, Suwa-shi, Nagano 392(JP) 3-5, Owa 3-chome Inventor: KUMAGAI, Toshio Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Representative: Lewin, John Harvey Inventor: TSUKAHARA, Michinari Elkington and Fife Seiko Epson Corporation, Prospect House CO 8 Pembroke Road o 3-5, Owa 3-chome CO Suwa-shi, Nagano 392(JP) Sevenoaks, Kent TN13 1XR (GB) &) INTERMEDIATE TRANSFER TYPE INK JET RECORDING METHOD.
    [Show full text]
  • Separation and Extraction of Proteins and Polysaccharides from the Seaweed Palmaria Palmata Using Enzyme Digestion
    Separation and Extraction of Proteins and Polysaccharides from the Seaweed Palmaria Palmata using Enzyme Digestion by Anna Nilsson Supervisor: Björn Viðar Aðalbjörnsson Co-supervisor: Ph.D. Johan Svensson Bonde Examiner: Professor Leif Bülow 2017 Department of Pure and Applied Biochemistry Faculty of Science Lund University SE-221 00 Lund, Sweden Copywright © 2017 Anna Nilsson All rights reserved Printed in Sweden by Media-Tryck, Lund, 2017 DEPARTMENT OF CHEMICAL ENGINEERING LUND UNIVERSITY P.O. BOX 124 SE-221 00 LUND, SWEDEN ii Organization Document name Lund University Master thesis Date of issue April 2017 Author Anna Nilsson Title and subtitle Separation and Extraction of Proteins and Polysaccharides from the Seaweed Palmaria Palmata using Enzyme Digestion Key words Palmaria palmata, dulse, enzyme digestion, separation, protease, xylan, xylose, seaweed, xylanase Language English, Swedish Recipient’s notes Number of pages 67 iii PREFACE This master thesis was possible thanks to Matís, a food and biotechnology R&D institute located in Reykjavik, Iceland. It commenced 1st of February 2016 and ended with a presentation held the 27/4 2017. The purpose of the project was to find a method of enzymatic extraction of polysaccharides and proteins in Palmaria palmata (P. palmata) a red seaweed. The project focuses mainly on extraction using proteases, which catalyse the hydrolysis of proteins, and xylanase, that catalyse the hydrolysis of xylan. Xylan is the main polysaccharide in P. palmata. The findings intend to be beneficial and useful within the human food and animal feed industry. These new methods and ways to utilize this large ocean resource may lead to more sustainable and environmental solutions compared to already existing terrestrial options such as soy and other grains.
    [Show full text]
  • Expression and Structure-Functional Studies of Human Apolipoproteinciii
    Haiqun Liu EXPRESSION AND STRUCTURE-FUNCTIONAL STUDIES OF HUMAN APOLIPOPROTEINCra A thesis submitted in accordance with the regulations of the University of London for the degree of Doctor of Philosophy October 2000 Centre for the Genetics of Cardiovascular Disorders Department of Medicine The Rayne Institute University College London ProQuest Number: U642127 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest U642127 Published by ProQuest LLC(2015). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 ABSTRACT Apolipoprotein (Apo) CHI plays a key role in triglyceride (TG)-rich lipoprotein metabolism and is a risk factor for coronary heart disease (CHD). The study involved in this thesis is the first in vitro structure-functional study using recombinant apoCni proteins. The physicochemical properties of recombinant wild type and A23T, a naturally occurring mutation that is associated with apoCIII deficiency and lower plasma TG levels, as well as three site-directed mutants of apoCIII, designed by molecular modelling and implicated in lipid binding (L9T/T20L, F64A/W65A) or lipoprotein lipase (LPL) inhibition (K21A), were compared. Relative lipid binding efficiencies of each apoCIII variants to 1.2-dimyristoyl-sn-glycero-3- phosphatidylcholine (DMPC) were: L9T/T20L>WT>K21A>A23T>F64A/W65A with an inverse correlation with size of the discoidal complexes formed.
    [Show full text]
  • Structures and Characteristics of Carbohydrates in Diets Fed to Pigs: a Review Diego M
    Navarro et al. Journal of Animal Science and Biotechnology (2019) 10:39 https://doi.org/10.1186/s40104-019-0345-6 REVIEW Open Access Structures and characteristics of carbohydrates in diets fed to pigs: a review Diego M. D. L. Navarro1, Jerubella J. Abelilla1 and Hans H. Stein1,2* Abstract The current paper reviews the content and variation of fiber fractions in feed ingredients commonly used in swine diets. Carbohydrates serve as the main source of energy in diets fed to pigs. Carbohydrates may be classified according to their degree of polymerization: monosaccharides, disaccharides, oligosaccharides, and polysaccharides. Digestible carbohydrates include sugars, digestible starch, and glycogen that may be digested by enzymes secreted in the gastrointestinal tract of the pig. Non-digestible carbohydrates, also known as fiber, may be fermented by microbial populations along the gastrointestinal tract to synthesize short-chain fatty acids that may be absorbed and metabolized by the pig. These non-digestible carbohydrates include two disaccharides, oligosaccharides, resistant starch, and non-starch polysaccharides. The concentration and structure of non-digestible carbohydrates in diets fed to pigs depend on the type of feed ingredients that are included in the mixed diet. Cellulose, arabinoxylans, and mixed linked β-(1,3) (1,4)-D-glucans are the main cell wall polysaccharides in cereal grains, but vary in proportion and structure depending on the grain and tissue within the grain. Cell walls of oilseeds, oilseed meals, and pulse crops contain cellulose, pectic polysaccharides, lignin, and xyloglucans. Pulse crops and legumes also contain significant quantities of galacto-oligosaccharides including raffinose, stachyose, and verbascose.
    [Show full text]
  • Chapter 3: the Chemical Basis for Life Lesson 2: Organic Compounds
    Chapter 3: The Chemical Basis for Life Lesson 2: Organic Compounds We have already learned that water is the primary substance for life on Earth, but we will now explore the element found in most of the molecules from which living organisms are made. That element is carbon and it is found in all organic compounds. The picture above is a graphic depiction of the organic compounds: carbohydrates, proteins, lipids, and nucleic acids. These are all large complex molecules that have contributed to the great diversity of life on Earth. Lesson Objectives • Define and explain elements and compounds; the relationships from atom to molecule to macromolecule. • Explain why carbon is essential to life on Earth and uniquely suited to form biological macromolecules. • Describe and compare the structure and function of the four major types of organic compounds. Vocabulary • atom biochemical conversion biological macromolecule carbohydrate DNA (deoxyribonucleic acid) isomers lipids macromolecules molecule monomer nucleic acid organic molecule polymer protein 63 INTRODUCTION If you look at your hand, what do you see? Of course, you see skin, which consists of cells. But what are skin cells made of? Like all living cells, they are made of matter. In fact, all things are made of matter. Matter is anything that takes up space and has mass. Matter, in turn, is made up of chemical substances. In this lesson you will learn about the chemical substances that make up living things. CHEMICAL SUBSTANCES A chemical substance is matter that has a definite composition. It also has the same composition throughout. A chemical substance may be either an element or a compound.
    [Show full text]
  • University of Huddersfield Repository
    University of Huddersfield Repository Ngehnyuiy, Ngo Hansel Characterisation of Bacterial Polysaccharides Original Citation Ngehnyuiy, Ngo Hansel (2020) Characterisation of Bacterial Polysaccharides. Doctoral thesis, University of Huddersfield. This version is available at http://eprints.hud.ac.uk/id/eprint/35297/ The University Repository is a digital collection of the research output of the University, available on Open Access. Copyright and Moral Rights for the items on this site are retained by the individual author and/or other copyright owners. Users may access full items free of charge; copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational or not-for-profit purposes without prior permission or charge, provided: • The authors, title and full bibliographic details is credited in any copy; • A hyperlink and/or URL is included for the original metadata page; and • The content is not changed in any way. For more information, including our policy and submission procedure, please contact the Repository Team at: [email protected]. http://eprints.hud.ac.uk/ CHARACTERISATION OF BACTERIAL POLYSACCHARIDES NGO HANSEL NGEHNYUIY, MSc A thesis submitted to the University of Huddersfield in partial fulfilment of the requirements for the degree of Doctor of Philosophy Department of Chemical and Biological Sciences School of Applied Sciences The University of Huddersfield March 2020 i ABSTRACT A number Gram-positive bacterial strains including Lactobacillus paracasei DG, Lactobacillus salivarius CCUG44481 and Bifidobacteria breve 7017 have been known to possess probiotic properties which has led to their increasing use in commercial probiotic products.
    [Show full text]
  • Apparatus for Auto-Pretreating Sugar Chain
    (19) & (11) EP 2 207 030 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC (43) Date of publication: (51) Int Cl.: 14.07.2010 Bulletin 2010/28 G01N 27/62 (2006.01) G01N 30/06 (2006.01) G01N 30/72 (2006.01) G01N 30/88 (2006.01) (2006.01) (21) Application number: 08836267.8 G01N 35/04 (22) Date of filing: 03.10.2008 (86) International application number: PCT/JP2008/068111 (87) International publication number: WO 2009/044900 (09.04.2009 Gazette 2009/15) (84) Designated Contracting States: • MIURA, Yoshiaki AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Sapporo-shi HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT Hokkaido 001-0021 (JP) RO SE SI SK TR • YAMAZAKI, Hiroshi Designated Extension States: Hachioji-shi AL BA MK RS Tokyo 192-0031 (JP) • HORIUCHI, Michio (30) Priority: 05.10.2007 JP 2007262771 Hachioji-shi 05.10.2007 JP 2007262680 Tokyo 192-0031 (JP) • MOTOKI, Hiroaki (71) Applicants: Hachioji-shi • Hokkaido University Tokyo 192-0031 (JP) Kita-ku • KURODA, Toshiharu Sapporo-shi Hachioji-shi Hokkaido 060-0808 (JP) Tokyo 192-0031 (JP) • SYSTEM INSTRUMENTS CO., LTD. •KITA,Yoko Hachioji-shi, Tokyo 192-0031 (JP) Amagasaki-shi • Shionogi&Co., Ltd. Hyogo 660-0813 (JP) Osaka-shi, Osaka 5410045 (JP) • NAKANO, Mika Amagasaki-shi (72) Inventors: Hyogo 660-0813 (JP) • NISHIMURA, Shinichiro Sapporo-shi (74) Representative: Guder, André Hokkaido 001-0021 (JP) Uexküll & Stollberg • SHINOHARA, Yasuro Patentanwälte Sapporo-shi Beselerstraße 4 Hokkaido 001-0021 (JP) 22607 Hamburg (DE) (54) APPARATUS FOR AUTO-PRETREATING SUGAR CHAIN (57) To provide an autoanalyzer for analyzing a sug- for the mass spectrometry having the captured sugar ar chain contained in a biological sample, in particular, chain dotted thereon which comprises the step of provid- serum.
    [Show full text]